Forum convention
Timing and details
Loading…
Also known as: Long R3 IGF-I · LR3IGF-I · IGF LR3 · Long Arg3 IGF-1
Updated 20 sources
How it is thought to work. LR3 swaps in arginine at position 3 and adds a 13-amino-acid tail. Its binding to IGFBP-3 is about 1000-fold lower than native IGF-1, so it acts on the IGF-1 receptor directly. In cells it was 5 to 10 times as potent as IGF-1, and in rats 6 times as potent for growth. Unlike GH secretagogues, it skips the pituitary entirely.
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Doses shown are what sources report, labelled by origin. Not medical advice.
Full IGF-1 LR3 dosage guideEvery titration step in syringe units, missed doses and how to mix.| Water | Strength | 20 mcgdose, units | 40 mcgdose, units | 50 mcgdose, units |
|---|---|---|---|---|
| 1 mg vial | ||||
| 1 mLCompetitor guide | 1 mg/mL | 20.02 mL | 40.04 mL | 50.05 mL |
| 2 mLCompetitor guide | 0.5 mg/mL | 40.04 mL | 80.08 mL | 100.1 mL |
| 3 mLCompetitor guide | 0.333 mg/mL | 60.06 mL | 120.12 mL | 150.15 mL |
Doses shown are what sources report, labelled by origin. Not medical advice.
Calculate with this peptideYour vial, your water, your dose: IGF-1 LR3 in syringe units, with the math shown.Community-reportedFrom 572 Reddit posts and comments, last mined Oct 23, 2026r/Peptides, r/Biohackers, r/Peptidesource, r/PeptideDiscussion
Muscle growth36 mentions
| Reported | Mentions |
|---|---|
| 50 mcg | 12 |
| 30 mcg | 8 |
| 20 mcg | 5 |
| 100 mcg | 5 |
| 25 mcg | 2 |
Goal not stated31 mentions
| Reported | Mentions |
|---|---|
| 50 mcg | 10 |
| 20 mcg | 5 |
| 40 mcg | 5 |
| 100 mcg | 4 |
| 400 mcg | 4 |
Left out: 5 mentions far outside every sourced protocol, most likely vial sizes or typos.
| Reported | Mentions |
|---|---|
| Once a day | 21 |
| 5 days on, 2 off | 3 |
| As needed | 3 |
| Three times a week | 2 |
Low blood sugar6 mentions
Most common fix: eat carbs or sugar (2)
Swelling3 mentions
Fainting2 mentions
Most common fix: eat carbs or sugar (2)
Fast heart rate2 mentions
Fatigue2 mentions
Carpal tunnel2 mentions
Doses shown are what sources report, labelled by origin. Not medical advice.
From clinical trials and regulatory documents.
A theoretical concern from IGF-1 receptor biology. No human data exist either way
Mecasermin's label lists severe hypoglycemia, raised pressure inside the skull, enlarged tonsils and malignant neoplasia. It is a different molecule, but the same receptor
How people manage it
From community reports and dosing guides. Not measured rates.
The main acute concern in guides, especially at 50 mcg and above. One guide states a 20 to 30% risk with no source. Approved IGF-1 has caused severe hypoglycemia
How people manage it
Reported by guides
Reported by guides
Reported by guides in weeks 1 to 2
Fridge at 2 to 8 °C, good for 12 to 24 months per one guide. Another allows room temperature or fridge.
Fridge, 2 to 8 °C. Guides give 14 to 30 days, with 28 days as a common figure. Freezing aliquots has not been shown to extend it.
Mixed with: Bacteriostatic water
Mixing. 1 mg is the only vial size found. Doses are tiny, often 2 to 4 units on a U-100 syringe, so the volume you pick changes how precise each draw is. Guidance on acetic-acid reconstitution was not found.
LR3 after training, ipamorelin 200 to 300 mcg before bed.
Paired with CJC-1295 with DAC at 2 mg a week.
MK-677 at 12.5 to 25 mg nightly. Guides say to watch insulin sensitivity.
No peer-reviewed human studies. Evidence is cell work and rat studies on binding, potency and clearance. It was made as a cell-culture growth reagent; one black-market vial even held a His-tagged lab version. Every dose here is a community or guide convention.
No approval, no trial program and not on FDA's compounding lists.
Not FDA approved. It is a different molecule from mecasermin (Increlex), the approved recombinant IGF-1 (BLA 021839, approved August 30, 2005). Not named on FDA's 503A category lists or the compounding safety-risk page.
WADA 2026 bans IGF-1 and its analogues at all times under S2.3.
WADA: Prohibited
20 to 40 mcg a day is the convention. Guides top out around 50 mcg. Self-logged entries run from about 10 to 100 mcg.
After training or with a meal, with carbs. That is the opposite of GH secretagogues, which people take fasted.
Guides use 1, 2 or 3 mL. At 1 mL, 20 mcg is 2 units on a U-100 syringe; at 2 mL it is 4 units. Use the calculator for your own numbers.
It has not been measured in humans. The 20 to 30 hour figure on many sites has no human source. In rats, LR3 cleared about 10 times faster than native IGF-1 because it does not ride on binding proteins.
Approved IGF-1 can, and guides warn the same for LR3. Take it with food and keep fast carbs on hand.
4 to 6 weeks on, then the same time off. Some guides use 2 to 4 weeks off.
Some do, 10 to 20 mcg into each side of a trained muscle after a workout.
There is no human trial, so before-and-after claims are anecdotal.
No. Increlex (mecasermin) is native-sequence IGF-1 and FDA approved for children with severe primary IGF-1 deficiency, dosed by body weight twice daily with food. It is not a dose reference for LR3.
DES is a shorter, short-acting variant used locally after workouts.
GH works upstream and raises IGF-1 indirectly. LR3 acts on the IGF-1 receptor directly.
One guide lists kidney disease as a do-not-use, based on a rat study where kidney failure changed how LR3 was cleared.
Yes. WADA lists IGF-1 and its analogues under S2.3, banned at all times.
Answers come from this site's pages only, with a link to each source.
20 sources, each checked by date. Record updated Oct 23, 2026. Numbers are restated in our own words and labelled by where they came from.